Update on EU actions to support availability of medicines during COVID-19 pandemic

The European Medicines Agency, together with Pharma, is currently setting up the i-SPOC (industry single point of contact) system through which Pharma can report directly to Agency any issues related to availability of crucial medicines being used in the context of COVID-19.

SPS commentary:

The European medicines regulatory network is compiling a list of the medicines currently being employed across the EU to treat patients with COVID-19. A subset of the medicines used in ICUs which are at greater demand will be closely monitored for any possible disruption in the supply using the i-SPOC system.


European Medicines Agency